Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.75
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $10.16 billion as of August 24, 2026. Its market cap has increased by 381.70% in one year.
Market Cap
10.16B
Enterprise Value
8.88B
1-Year Change
381.70%
Ranking
Category
Stock Price
$134.75
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $10.16B, an increase of 1,156.32%. That is a compound annual growth rate of 125.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 10.16B | 99.49% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 11.12B |
| Axsome Therapeutics | 10.88B |
| Cytokinetics | 10.68B |
| Summit Therapeutics | 10.50B |
| Praxis Precision Medicines | 10.50B |
| Krystal Biotech | 10.26B |
| Protagonist Therapeutics | 9.99B |
| Kymera Therapeutics | 9.96B |